Exelixis (EXEL) Gross Profit (QoQ) (2013 - 2026)
Exelixis (EXEL) Gross Profit (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Exelixis | 14.46 Bn | 13.68 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.26% |
| Jan 2, 2026 | -1.21% |
| Oct 3, 2025 | 5.54% |
| Jul 4, 2025 | 2.33% |
| Apr 4, 2025 | -1.92% |
| Jan 3, 2025 | 4.71% |
| Sep 27, 2024 | -15.71% |
| Jun 28, 2024 | 53.36% |
| Mar 29, 2024 | -11.78% |
| Dec 29, 2023 | 1.05% |
| Sep 29, 2023 | 0.22% |
| Jun 30, 2023 | 14.62% |
| Mar 31, 2023 | -3.31% |
| Dec 30, 2022 | 2.92% |
| Sep 30, 2022 | -2.34% |
| Jul 1, 2022 | 18.43% |
| Oct 1, 2021 | -14.51% |
| Jul 2, 2021 | 44.06% |
| Apr 2, 2021 | 0.26% |
| Jan 1, 2021 | 15.29% |